Table 4.

Comparison of adverse events of MMF and CYC therapy

Parameter	CYC (N = 21)	MMF (N = 21)	P value	Odds ratio	95% Confidence interval
Alopecia	16 (76.2%)	0 (0.00%)	<.001	n/a	n/a
Nausea/Vomiting	16 (76.2%)	0 (0.0%)	<.001	n/a	n/a
Headache	8 (38.09%)	4 (19.04%)	0.778	0.423	0.084–3.456
Backache	6 (28.57%)	4 (19.04%)	0.887	0.632	0.094–4.230
Urinary tract infection	4 (19.04%)	2 (9.52%)	0.796	0.473	0.083–3.492
Herpes Zoster	3 (14.3%)	3 (14.3%)	0.337	1.000	0.178–5.632
Chest Infection	3 (14.3%)	2 (9.5%)	0.328	0.632	0.094–4.230